...
Details on Available Reports
...
PATIENT LISTS
View All Patient Lists
Generate Generates a list of patients. List can be filtered by basic characteristics, with optional . Options available to control the data output.
Determining which patients are to be included in the list |
|
|---|---|
| |
Choose which data points to be included in the list. | Screenshots |
|---|---|
There are three options to control the format of the output data: Basic Details, MDR-TB Short Summary, and Custom. | |
| |
| |
| |
Active MDR-TB Patients
This links to the Patient List Generator, defaulted to only include patients currently enrolled in the MDR-TB Program. See above for details on the Patient List Generator.
Cohort Builder
Details on the Cohort Builder to come soon.
...
REPORTS
WHO Form 05
Quarterly report on MDR-TB detection and Category IV treatment start
...
- Ensure that all patients with an intake form or lab result recorded have been enrolled in the MDR-TB program at a location.
- Ensure that all DST results are up-to-date.
- Ensure that initial drug regimens have been entered.
- Ensure that the workflow state “Registration Group – Previous Drug Use” is up to date for all patients
WHO Form 06
Six month interim outcome assessment of confirmed MDR-TB cases (to be filled out 9 months after treatment start)
...
- Ensure that all patients with an intake form or lab result recorded have been enrolled in the MDR-TB program at a location.
- Ensure that treatment start dates are correct.
- Ensure that all smear and culture results have been entered.
- Ensure that patient outcomes are up to date (and that outcome dates are correct).
- Check for suspected defaulters who have not had outcome updated (look for patients without an encounter in the last two months)
WHO Form 07
Annual report of treatment result of confirmed MDR-TB patients starting Category IV treatment (to be filled in 24 and 36 months past the closing date of year of treatment)
...
All are calculated based on the MDR-TB program workflow “CLASSIFICATION ACCORDING TO PREVIOUS DRUG USE”. See definitions in WHO Form 05 section.
- New
- Previously treated with first-line drugs only
- Previously treated with both first- and second-line drugs.
...
- Ensure that all patients with an intake form or lab result recorded have been enrolled in the MDR-TB program at a location.
- Ensure that treatment start dates are correct.
- Ensure that all smear and culture results have been entered and that conversion status is correct.
- Ensure that patient outcomes are up to date (and that outcome dates are correct).
- Check for patients who meet the criteria of “Cured”, “Completed”, “Failed” and “Defaulted” but are not set to that state, and vice versa
- Check for patients who do not have a PREVIOUS DRUG USE status.
Outcome Report
Report on patient outcomes by Category IV registration group for patients who started treatment during a given time period
Base cohort: All patients enrolled in MDR-TB program at reporting location who started treatment on any tuberculosis regimen during the specified year (and quarter/month if specified).
...
- New: The patient has never received treatment, or if the patient has received less than one month of treatment at the time of collection of the sputum sample that was used to confirm MDR-TB.
- Relapse: The patient previously completed treatment, and the outcome of the previous treatment was “cured” or “treatment completed”.
- After Defaulted: Patients who are returning to treatment following an interruption of treatment for two or more consecutive months.
- After failure of Category I Treatment: The patient failed treatment after taking RHEZ
- After failure of Category II Treatment: The patient failed treatment after taking second line drugs.
- Transferred In: The patient is transferring from another site where they were taking Category IV treatment.
- Other: Patients who do not fit into any of the given categories.
- Unknown
- Total
MDR-TB Indicator Report
Report on MDR-TB treatment to be completed monthly and quarterly
...
- Returns the number of patients with a particular resistance pattern, e.g. R+H+E+S.
Specimen Reports
Parameters: Specimen collection date (start date and end date) and testing facility. Also time frame in which we should expect culture results after a positive smear, and the time frame in which we should expect DST results after a positive culture results.
...
- Specimens with positive smear results but no culture results: Collected in specified date range, with no culture results after the specified number of days.
- Specimens with positive culture results but no DST results: Collected in specified date range, with no DST results after the specified number of days.
- Specimens reported as contaminated: Collected in specified date range.
- Specimens with no test results: Collected in specified date range.
Resistance Profiles
Lists all patients who are resistant to at least one drug.
...
Output: Patients name, enrollment date, and resistance profile, e.g INH+R+H+S..
...
DRUG REQUIREMENTS ANALYSIS
Drug Usage
Parameters: Drug Group (e.g. TB Drugs), Date range (Beginning and End)
- Average Daily Use: The daily usage of all medications active within the specified date range.
- Total Quantity Required: The average daily usage multiplied by the number of days in the specified date range.
- Price per unit: To be manually added.
- Cost for this drug: Total quantity required multiplied by the price per unit.
Number of patients taking each drug
Returns the number of patients taking each drug on the day specified.